Skip to content

The study of changes in the blood level of the mineralocorticoid receptor in patients with liver cirrhosis

The study of changes in the blood level of the mineralocorticoid receptor in patients with liver cirrhosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099090
Enrollment
Unknown
Registered
2025-03-18
Start date
2025-03-28
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis

Interventions

Control group:None

Sponsors

Jing'an District Central Hospital Of Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Those who intend to undergo liver laparotomy or liver puncture for various reasons or non-liver diseases come to the hospital for physical examination, outpatient and hospitalization; 2. Age 20-95 years old; 3. Ability to understand and sign informed consent and comply with study requirements.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating females; 2. Suffering from major diseases such as uncontrollable infectious and inflammatory diseases, renal failure, malignant tumors, psychiatric diseases, uncontrollable systemic autoimmune diseases other than autoimmune liver disease (such as glomerulonephritis, systemic lupus erythematosus, arthritis); 3. Not agreeing to participate in this study as a subject or not signing the informed consent form.

Design outcomes

Primary

MeasureTime frame
Liver cirrhosis;

Countries

China

Contacts

Public ContactZhuxia Shen

Jing'an District Central Hospital Of Shanghai

zjushenzx@126.com+86 21 61578236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026